Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 102.05

+0.3%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (856)	2/16/1999 9:19:00 AM
From: LLCF	of 3202

AFFX announced that they have entered into an EasyAccess(TM) Silver agreement with the Parke-Davis Pharmaceutical Division of Warner_Lambert Company. Park-Davis will gain preferential access to Affymetrix' standard and custom GeneChip(R) arrays, intrumentation and software to monitor gene expression for use in theri reasearch and development activities. "We are delighted witht he growing acceptance of our EasyAccess program and commitment of our customers to the GeneChip platform." This is a quick overview... can't get the news on Yahoo yet... DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next